Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLYATL1 antisense RNA 1 (GLYATL1-AS1) is a long non-coding RNA (lncRNA) gene located antisense to the GLYATL1 gene. Antisense lncRNAs typically regulate the expression of their sense gene partner or other genes at the transcriptional or post-transcriptional level, though the specific biological and disease roles of GLYATL1-AS1 have not been conclusively described. This lncRNA does not encode a protein and has not been directly established as a therapeutic target or biomarker in the current literature. Further research is needed to clarify its potential functions and disease associations[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLYATL1 antisense RNA 1 (GLYATL1-AS1).